
    
      After inclusion in the trial, stereotactic biopsy will be performed. In the same surgery, the
      experimental agent will be injected also by stereotactic system, in a different part of the
      lesion, in a region considered viable tumor, using a cannula especially designed for virus
      injection.

      Follow-up will include clinical visits and MRI No other treatment for the tumor will be used
      until progression is documented. iRANO criteria and volumetric measurement of the tumor will
      be used.

      Any further treatment after progression will be at the criteria of the treating physician
    
  